ANA-positive <i>versus</i> ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)Irene Cecchi, Savino Sciascia, Paul R. Fortin et al.|Lara D. Veeken|2024Cited by 9
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)Cécile Yelnik, Doruk Erkan, Zeynep Belce Erton et al.|Seminars in Arthritis and Rheumatism|2023Cited by 7
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”)Zeynep Belce Erton, Doruk Erkan, Rebecca Karp Leaf et al.|Lupus|2025Cited by 2
POS0200 TYPE I INTERFERON ACTIVITY IN PERSISTENTLY ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PATIENTS WITH OR WITHOUT LUPUS: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) CLINICAL DATABASE AND REPOSITORY (“REGISTRY”)Romy Kallas, Doruk Erkan, Andrra Nimoni et al.|Annals of the Rheumatic Diseases|2025Cited by 0
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory DomainsMedha Barbhaiya, Thomas Dörner, Stéphane Zuily et al.|Current Rheumatology Reports|2025Cited by 0